We are live on ! Find out more
ACM

Altium Capital Management Portfolio holdings

AUM $42M
This Fund
S&P 500
This Quarter Est. Return
+2.29%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$363M
AUM Growth
-$18.6M
Cap. Flow
+$5.56M
Cap. Flow %
1.53%
Top 10 Hldgs %
25.94%
Holding
173
New
49
Increased
12
Reduced
23
Closed
40

Top Buys

Rank Stock Value
1
ESPR
Esperion Therapeutics
ESPR
+$20.1M
2
PEPL
PepperLime Health Acquisition Corporation Class A Ordinary Share
PEPL
+$7.18M
3
CBAY
Cymabay Therapeutics
CBAY
+$6.64M
4
NSTG
NanoString Technologies, Inc.
NSTG
+$6.41M
5
QDEL icon
QuidelOrtho
QDEL
+$5.15M

Top Sells

Rank Stock Value
1
ALDX icon
Aldeyra Therapeutics
ALDX
+$7.59M
2
ARQT icon
Arcutis Biotherapeutics
ARQT
+$6.09M
3
CDNA icon
CareDx
CDNA
+$5.7M
4
HAE icon
Haemonetics
HAE
+$5.22M
5
LITS
Lite Strategy Inc
LITS
+$5.04M

Sector Composition

Rank Sector Weight
1 Healthcare 79.63%
2 Financials 7.92%
3 Technology 1.93%
4 Industrials 1.24%
5 Communication Services 0.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HCDIZ
101
DELISTED
Harbor Custom Development, Inc. Warrant
HCDIZ
$501K 0.14%
+650,000
New +$373K
PSQH icon
102
PSQ Holdings
PSQH
$14.1M
$482K 0.13%
3,333
– –
ICAD
103
DELISTED
iCAD Inc
ICAD
$460K 0.13%
63,929
-256,071
-80% -$2.28M
IMMX icon
104
Immix Biopharma
IMMX
$678M
$436K 0.12%
+122,388
New +$419K
PALI icon
105
Palisade Bio
PALI
$361M
$434K 0.12%
+445
New +$778K
IMTXW
106
DELISTED
Immatics N.V. Warrants
IMTXW
$428K 0.12%
97,467
– –
RCOR.WS
107
DELISTED
Renovacor, Inc. Warrants, entitling the holder thereof to purchase one-half (1/2) of a share of common stock at a price of $11. 50 per whole share
RCOR.WS
$417K 0.12%
731,561
– –
MDXH icon
108
MDxHealth
MDXH
$22.8M
$344K 0.09%
+36,159
New +$354K
HSDT icon
109
Solana Company
HSDT
$100M
$254K 0.07%
+1
New +$356K
HCDIW
110
DELISTED
Harbor Custom Development, Inc. Warrant
HCDIW
$234K 0.06%
600,000
– –
CING icon
111
Cingulate
CING
$69.1M
$232K 0.06%
+350
New +$247K
AGIL
112
DELISTED
AgileThought Inc
AGIL
$225K 0.06%
+47,670
New +$410K
MYSZ icon
113
My Size
MYSZ
$1.79M
$210K 0.06%
+2,083
New +$399K
MBTCR
114
DELISTED
Nocturne Acquisition Corporation Right
MBTCR
$200K 0.06%
500,000
– –
CINGW icon
115
Cingulate Inc Warrants
CINGW
$28.9K
$192K 0.05%
+270,000
New +$198K
NXGLW icon
116
NexGel Inc Warrant
NXGLW
$182K 0.05%
+225,000
New +$183K
PEPLW
117
DELISTED
PepperLime Health Acquisition Corporation Warrrant
PEPLW
$165K 0.05%
+367,500
New +$174K
SURGW
118
DELISTED
SurgePays, Inc. Warrant
SURGW
$161K 0.04%
+250,000
New +$178K
NLSPW
119
DELISTED
NLS Pharmaceutics Warrant
NLSPW
$146K 0.04%
+200,000
New +$129K
LAAAW
120
DELISTED
Lakeshore Acquisition I Corp. Warrant
LAAAW
$116K 0.03%
150,000
– –
OBIO icon
121
Orchestra BioMed
OBIO
$254M
$101K 0.03%
10,000
– –
SRZNW icon
122
Surrozen Inc Warrant
SRZNW
$22.4K
$95K 0.03%
82,233
– –
EUCRW
123
DELISTED
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
$77K 0.02%
133,333
– –
NXGL icon
124
NexGel
NXGL
$3.3M
$75K 0.02%
+28,570
New +$84.2K
MOBXW icon
125
Mobix Labs Warrants
MOBXW
$752K
$74K 0.02%
150,000
– –
3 4
5
6 7

Similar funds

TA
TLS Advisors Miami, Florida $42.1M AUM 25.99% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
VEPM
Vista Equity Partners Management San Francisco, California $42.7M AUM 16.65% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
VAM
Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return
SCM
Stadium Capital Management New Canaan, Connecticut $40.6M AUM 5.83% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return

Altium Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Altium Capital Management held 173 positions worth $363M, down 4.9% from $381M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Altium Capital Management's Q4 2021 filing shows 49 new, 12 increased, 23 reduced and 40 closed positions. Its largest new stake was Esperion Therapeutics: 2,515,785 shares worth $12.6M. The largest sale was Aldeyra Therapeutics, an estimated $7.59M.

By sector, the portfolio is most concentrated in Healthcare at 80% of assets, down from 82% a quarter earlier, followed by Financials and Technology.

  • Altium Capital Management's largest Q4 2021 buy was Esperion Therapeutics: 2,515,785 shares worth $12.6M.
  • Altium Capital Management added most to Bicycle Therapeutics in Q4 2021, an estimated $4.41M increase.
  • Altium Capital Management's biggest Q4 2021 reduction was Cerus, cutting an estimated $4.27M.
  • Altium Capital Management fully exited Aldeyra Therapeutics in Q4 2021, selling an estimated $7.59M.
  • Altium Capital Management's ten largest holdings make up 26% of its $363M portfolio in Q4 2021.
  • Altium Capital Management opened 49 new positions and closed 40 in Q4 2021.
  • Altium Capital Management's portfolio value fell 4.9% quarter-over-quarter to $363M.

Based on Altium Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.